The Prevalence of Transmitted Resistance to First-Generation Non-Nucleoside Reverse Transcriptase Inhibitors and Its Potential Economic Impact in HIV-Infected Patients

Lignende værker

• Burden of Nonnucleoside Reverse Transcriptase Inhibitor Resistance in HIV-1-Infected Patients: A Systematic Review and Meta-Analysis
  af: Snedecor, Sonya J., et al.
  Udgivet: (2014)
• Cost of Treatment in a US Commercially Insured, HIV-1–Infected Population
  af: Solem, Caitlyn T., et al.
  Udgivet: (2014)
• Structural insights into the recognition of nucleoside reverse transcriptase inhibitors by HIV‐1 reverse transcriptase: First crystal structures with reverse transcriptase and the active triphosphate forms of lamivudine and emtricitabine
  af: Bertoletti, Nicole, et al.
  Udgivet: (2019)
• Combination Nucleoside/ Nucleotide Reverse Transcriptase Inhibitors
  af: Akanbi, Maxwell O, et al.
  Udgivet: (2012)
• Efficacy and safety of novel russian non-nucleoside reverse transcriptase inhibitor elsulfavirine in combination with 2 nucleoside/nucleotide reverse transcriptase inhibitors in first-line HIV treatment – 96-week study
  af: A. V. Kravchenko, et al.
  Udgivet: (2018-07-01)